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The thermal deactivation of TEM-1 β-lactamase was examined using two experimental techniques: a series of isothermal batch assays and a 
single, continuous, non-isothermal assay in an enzyme membrane reactor (EMR).  The isothermal batch-mode technique was coupled with the 
three-state “Equilibrium Model” of enzyme deactivation, while the results of the EMR experiment were fitted to a four-state “molten globule 
model”.  The two methods both led to the conclusions that the thermal deactivation of TEM-1 β-lactamase does not follow the Lumry-Eyring 
model and that the Teq of the enzyme (the point at which active and inactive states are in thermodynamic equilibrium) is at least 10°C from the 
Tm (melting temperature), contrary to the idea that the true temperature optimum of a biocatalyst is necessarily close to the melting temperature. 
Introduction 
The operational stability of a biocatalyst is an important 
characteristic in determining the suitability of that catalyst in a 
given process.  It is well-understood that catalytic activity tends to 
increase with temperature, but that in the case of enzymes, 
elevated temperature also leads to thermal deactivation due to a 
loss of integrity of the active site. [1, 2] When kept at elevated 
temperatures for extended time periods, enzymes will undergo 
denaturation to a permanently inactive state.  Some enzymes are 
capable of recovering catalytic activity after relatively short 
incubations at elevated temperatures which induce a loss of 
activity. [3, 4] The equilibrium model captures this phenomenon 
by including a reversible transition between active and inactive 
states, and has been shown to be valid for all of the enzymes 
(approximately 40) on which it has been tested. [5-8] 
 
 
 
Scheme 1.  Equilibrium Model 
 
     By treating the reversible transition between Eact and Einact as a 
van’t Hoff-type equilibrium, and the transition from Einact to X as a 
time-dependent, first-order decay with Arrhenius-type rate 
constant, one can derive an expression for the observed reaction 
rate as a function of temperature and elapsed time. [5, 6]  
Transition state theory is utilized to define the three quantities 
involved in the deactivation model, according to Equations 1-3.  
These are kcat (turnover number of enzyme), Keq (equilibrium 
constant between Eact and Einact), and kinact (first-order rate 
constant for decay from Einact to X).  The description of the Einact to 
X step in the Equilibrium Model is not intended to preclude the 
presence of multiple, inactive intermediate unfolding states, 
though it makes no distinction between such states. [8] 
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     Under isothermal conditions, the values of kcat, Keq, and kinact 
remain fixed, and depend only on the activation and deactivation 
parameters of the enzyme at that temperature: ΔGcat (activation 
energy for enzyme-catalysed reaction), ∆Ginact (activation energy 
for the Einact to X transition), ∆Heq (enthalpy change for the Eact to 
Einact transition), and Teq (temperature at which [Eact] = [Einact]). 
When isothermal conditions exist, the expression for the reaction 
rate Vmax, as a function of temperature and time, is given by 
Equation 4, where E0 is the initial enzyme concentration. 
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    By substituting the results of Equations 1-3 into Equation 4, the 
values of ΔGcat, ∆Ginact, ∆Heq, and Teq may be estimated by fitting 
experimental data of reaction rate vs. temperature vs. time to the 
model. [9] The established method for estimating these 
parameters is to perform an array of activity progress curves (i.e. 
including isothermal deactivation) while holding the initial enzyme 
concentration, E0, constant.  After several temperatures have 
been examined, all progress curves are fitted to a three-
dimensional surface plot using Powell’s algorithm to determine 
the global minimum of the sum of squares deviation between the 
experimental curves and the model. [9] 
 
     Recently, a method was developed for determining the 
optimum operating temperature for a biocatalyst using a single, 
continuous assay rather than an array of isothermal experiments. 
[10,11] This method utilizes an enzyme membrane reactor (for 
soluble enzyme) or a packed-bed reactor (for immobilized 
enzyme) to subject a single sample of enzyme to a continuous, 
positive, most often linear temperature gradient.  Since time and 
temperature are functionally related in such a linear ramp scheme, 
the reaction rate may be expressed as a function of a single 
variable (either time or temperature), plus all of the intrinsic 
activation and deactivation parameters listed in Equations 1-3. 
 
     Because certain enzymes are known to lose catalytic activity 
before the onset of complete unfolding (i.e. the global loss of 
secondary structure often associated with the Tm of the enzyme) 
[1], the model used with the continuous temperature ramp 
experiment assumes that the biocatalyst follows a four-state 
deactivation model.  This four-state model is similar to the 
equilibrium model but allows for two separate inactive states.  
The native state, N, is in equilibrium with a “molten globule” state, 
M, which has undergone slight conformational changes that 
render it inactive.  Here, states N and M are taken to be 
functionally equivalent to the Eact and Einact, respectively, of the 
equilibrium model. The four-state model includes a second 
equilibrium between M and another unfolded state, U, which has 
unfolded in the sense that it has experienced a widespread loss 
of secondary structure.  This “molten globule” unfolding model is 
shown in Scheme 2. 
 
 
 
Scheme 2.  Four-state “molten globule” deactivation model 
 
     The model in Scheme 2 assumes that the enzyme must first 
enter the unfolded state U before it may become permanently 
denatured and that there are no pathways for denaturation 
directly from the native or molten globule states.  Scheme 2 uses 
the same parameter as the equilibrium model, Keq, to describe the 
van’t Hoff equilibrium between states N and M.  The first-order 
denaturation constant for state U, kinact, is also the same for both 
models.  The molten globule model, however, contains the 
additional parameter, Kmg = [U]/[M], where: 
 
 
               (5) 
 
 
     Hence, the four-state model assumes a heterogeneous 
population of inactive enzyme and seeks to capture both the Teq 
and the traditional Tm of the enzyme.  Both of these values, which 
do not necessarily coincide with each other, are important when 
designing and characterizing a stable biocatalyst. [8] 
     When biocatalyst deactivation data is collected in a system 
which is operated as a continuous stirred-tank reactor, the degree 
of substrate conversion, X, is given as a function of temperature 
according to Equation 6. 
 
 
          (6) 
 
 
     Equation 6 contains the system parameters V (reactor volume), 
[S]0 (substrate feed concentration), and v (feed volumetric 
flowrate).  Both kcat and [N] vary over the course of the 
experimental run as temperature is ramped up, and are readily 
expressed as functions of either time or temperature in the case 
of a linear heating ramp (the relationship T = T0 + mt applies, 
where m is the rate of increase of the reactor temperature).  The 
value of kcat is given by Equation 1, and the value of [N] is derived 
by combining the definitions of Keq and Kmg, the mass balance on 
species N, M, U, and D, and the first-order denaturation rate law 
which states d[D]/dt = kinact[U]. 
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     Upon rearrangement, and application of the chain rule, 
Equation 9 is transformed into a first-order differential equation for 
which K1 = d(Keq)/dt and K2 = d(Kmg)/dt.  The rate of 
disappearance of native enzyme at any time (or temperature) 
according to Scheme 2 is given by Equation 10. 
 
 
                (10) 
 
 
     Unlike the three-state, isothermal Equilibrium Model in which 
all of the equilibrium constants and the deactivation rate constant 
are constant through the course of an experimental run, this four-
state, non-isothermal model equation is not readily integrated 
analytically.  However, provided that the continuous temperature 
ramp experiment is started at any temperature well below the Tm 
of the enzyme, such that Kmg << Keq, Equation 10 may be solved 
numerically by assuming an initial value of [N]0 = E0  / (1+Keq).   
 
     Essentially, the continuous ramp method uses variable Keq, kcat, 
and kinact, while the Equilibrium Model (in isothermal batch-mode) 
allows these all to be held constant.  Both methods, however, 
assume the intrinsic activation and deactivation parameters (ΔGcat, 
ΔGinact, ΔHeq, Teq) remain nearly constant over the entire 
temperature range of interest.   
 
     In this work, we have studied the thermal deactivation of an 
enzyme, TEM-1 β-lactamase from Escherichia coli, using both the 
isothermal batch techniques and the continuous EMR 
temperature ramp, on the same batch of enzyme, in order to 
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assess the relative strengths of the two methods.  Previously, a 
metallo-β-lactamase from Bacillus cereus has been studied using 
the batch-mode method with the equilibrium model, but a Class A 
β-lactamase such as TEM-1 has not been investigated to date 
using this method. [6, 12, 13] 
Experimental Section 
Materials 
TEM-1 β-lactamase (E.C. 3.5.2.6) was over-expressed in 
Escherichia coli and purified from the expression medium 
according to the method of Rogers et al. [11] Penicillin G 
potassium salt was purchased from USB Corp. (Cleveland, OH).  
Coomassie Protein Assay Reagent was obtained from Thermo 
Scientific (Rockford, IL).  All other chemicals used were of 
analytical grade. 
Batch-mode Experimental Setup 
Enzyme activity was measured using a Thermospectronic Helios 
γ-spectrophotometer equipped with a Thermospectronic single-
cell Peltier-effect cuvette holder.  This system was networked to a 
computer installed with Vision32 (Version 1.25, Unicam) software 
for recording absorbance vs. time data.  Quartz cuvettes with a 
5mm path length were used during the course of all experiments, 
due to their favourable optical and heat transfer properties.  The 
cuvette was kept isothermal during the course of each 
experimental run and a Cole-Parmer Digi-Sense thermocouple 
thermometer was used to ensure there was no temperature 
gradient larger than 0.1°C within the cuvette, or from the 
beginning to the end of the run.  Runs were discarded and 
repeated if a temperature gradient was detected.  The 
thermometer and the temperature control bath were calibrated 
using a Cole-Parmer NIST-traceable glass thermometer. 
Assay Conditions 
The reaction mixture consisted of an aqueous solution of 50 mM 
sodium phosphate buffer and 4.4 mM Penicillin G at pH 7.0.  For 
each run, 1.0 mL of reaction mixture was added to the cuvette, 
along with a 2-mm diameter teflon-coated stir wire, and the 
system was allowed to thermally equilibrate for a minimum of 5 
minutes.  A stock solution of enzyme, with concentration 
determined via Bradford assay (measurement of A280 in the 
presence of Coomassie Protein Assay Reagent), was used to 
prepare a sample with a final concentration of 32 μg/mL.  After 
thermal equilibration, 5 μL of the enzyme solution (for a total 
enzyme concentration of 5.5 nM) was injected directly into the 
cuvette using a positive displacement pipettor and the contents of 
the cuvette were agitated rapidly for 3 seconds using the 
preheated stir wire.  After stirring was completed, the software 
began recording absorbance data. 
     The hydrolysis of Penicillin G by TEM-1 β-lactamase was 
observed by monitoring the absorbance shift at 252 nm.  At this 
wavelength, the unreacted substrate exhibited an extinction 
coefficient of ε252 = 682 M-1 cm-1 and the fully hydrolyzed mixture 
exhibited an extinction coefficient of ε252= 213 M-1 cm-1.  This 
difference of 469 M-1 cm-1 between the substrate and product 
remained constant throughout the entire temperature range of 
this study.  The combination of substrate concentration, cuvette 
path length, and enzyme loading was chosen such that the 
starting absorbance never exceeded 1.5 AU (to preclude 
instrument saturation), and the substrate conversion never 
exceeded ~40% at any of the temperatures examined.  Hence, 
the substrate concentration was never lower than ~2.6 mM; a 
value over 100 times the published KM of the enzyme for Penicillin 
G at 25°C. [14] The linearity of the instrument response over the 
absorbance range 0.5-1.5 AU was confirmed by running a dilution 
series of unreacted substrate solution (R2 = 0.995).  Reactions 
were allowed to proceed for 120 seconds, with data points 
acquired at 2-second intervals. 
Batch-mode Data Analysis 
Triplicate assays were performed at each temperature, and the 
absorbance vs. time data were converted to reaction rate vs. time 
data.  The average of the three rates at each time point was used 
to construct a single progress curve of reaction rate vs. elapsed 
assay time for each given temperature.  The progress curves 
were smoothed using a Loess transformation (SigmaPlot 2001 for 
Windows) to eliminate noise from the data, and the smoothed 
curves for all temperatures were initially fitted to the equilibrium 
model using MATLAB, with initial parameter estimates of ΔGcat = 
85 kJ/mol, ΔGinact = 100 kJ/mol, ΔHeq = 120 kJ/mol, Teq = 320 K.  
The fitting parameters resulting from the first MATLAB run were 
used as improved initial estimates for a second MATLAB run, 
which provided the final values. [9]  
Continuous-mode EMR Experimental Setup 
The conversion vs. time data for the continuous temperature 
ramp experiment were collected in an enzyme membrane reactor 
according to the method of Rogers et al. [11] A single sample of 
enzyme was charged to a reactor with a working volume of 10.0 
mL and a solution of 200 mM sodium phosphate buffer and 20 
mM Penicillin G was continuously fed to the reactor at a rate of 
1.25 mL/min.  After a 1-hr equilibration period at the initial 
temperature of 295 K, the reactor temperature was progressively 
increased to 330 K using a linear temperature ramp of 2 K/hr. 
     The substrate conversion was monitored by measuring the 
optical rotation of the reactor effluent stream via an in-line 
polarimeter with a sample cell which was kept at 25°C by external 
water bath.  At 25°C, the specific optical rotation of the substrate 
mixture was α589 = 107° M-1 while that of the product was α589 = 
57° M-1. To account for background thermal degradation of the 
substrate, a calibration curve was constructed by first running 
pure unreacted feed and then completely hydrolysed product 
through the entire temperature ramp. 
Continuous-mode Data Analysis 
The conversion vs. time data were smoothed with the MATLAB 
Curve Fitting Toolbox, using a Robust Loess method with span = 
85.  The smoothed experimental data were fitted according to 
Equations 6 and 10, using an iterative solving procedure to 
minimize the sum of squared residuals by adjusting the fitting 
parameters.  Two different numerical techniques were used to 
solve the IVP of Equation 10: an implicit Euler method with a time 
interval of Δt = 120 seconds and an area-under-the-curve 
approximation per the trapezoidal rule, with a time interval of Δt = 
120 seconds. 
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     In addition, a model was generated which omitted the folding 
state, U, and assumed only a three-state model equivalent to the 
equilibrium model.  An attempt was then made to fit the 
continuous EMR data to this three-state model for purposes of 
comparison, using the area-under-the-curve approximation per 
the trapezoidal rule for the numerical integration. 
Results and Discussion 
Batch-mode Results 
A total of ten progress curves for the enzyme were measured, 
each in triplicate, over the temperature range from 292 K to 332 K.  
The temperature spacing between progress curves was varied 
through the course of the experiments, and two of the progress 
curves were measured at high temperatures such that the 
observed initial reaction rate had fallen below its peak value (i.e. 
the temperature was above Topt).  The experimental data for rate 
vs. temperature vs. time, overlaid with the rate predicted by the 
MATLAB routine according to Equation 4, is shown in Figure 1. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Isothermal Batch-mode (experimental vs. model) 
     Figure 2 depicts the experimental data from the continuous 
EMR temperature ramp experiment, overlaid with three different 
model predictions: the four-state molten globule model using the 
implicit Euler technique, the four-state molten globule model 
using the trapezoidal rule, and the three-state equilibrium model. 
The values of the deactivation parameters which were found by 
the various experimental methods and model fitting procedures 
are shown in Table 1. 
 Comparison of Models to Experimental Data 
Figures 1 and 2 show the experimental data for the batch-mode 
and continuous methods, respectively, overlaid with the 
predictions of the models.  One conspicuous feature of the 
experimental data for both the isothermal batch and temperature-
ramp methods is that the early (low-temperature) segment of the 
curve shows a near-linear increase of activity with temperature.  
Absent any deactivation effects in this regime, one would expect 
the curve to be concave upward, more closely resembling an 
Arrhenius-type activation profile.  The near-linear increase 
observed in the isothermal batch-mode data suggests the onset 
of activity loss at a temperature well below the traditional Tm of 
TEM-1 β-lactamase, which is 51.5°C as evidenced by 
interpretation of the circular dichroism spectrum. [15] It is clear 
that a different effect must be responsible for the observed 
activity loss in the vicinity of 310-315 K, more than 10°C below 
the Tm. This is contrary to the widely-held idea that the optimum 
operating temperature of a biocatalyst is very close (within a 
degree or two) of its melting temperature, but is expected for an 
enzyme following the Equilibrium Model. [10, 16] This may only 
hold true for those enzymes for which global secondary structure 
and active site integrity are compromised simultaneously. 
 
 
 
 
 
 
 
 Figure 2.  Continuous Temperature-ramp EMR (fitted to models) 
     The three-state deactivation model resulted in a relatively poor 
fit to the continuous non-isothermal data from the EMR.  Similar 
to the fit of the Equilibrium Model to the batch results in Figure 1, 
the three-state deactivation model, numerically integrated via the 
trapezoidal rule, tends to underestimate the enzyme activity on 
the low-temperature end of the EMR experiment, anticipating an 
Arrhenius-type increase as temperature rises.  It can be clearly 
seen that the predicted slope of the rate vs. temperature trend, in 
the low-temperature regime, is significantly greater than that of 
the experimental data, for both the three-state batch and three-
state temperature-ramp models. 
     Notably, however, the three-state isothermal Equilibrium 
Model (MATLAB routine) resulted in a relatively good fit to the 
batch data in the high temperature regime, particularly near the 
Teq of 314 K, while the three-state EMR model was unable to 
converge upon a good fit in this regime.  One explanation for this 
could be the large difference in time scales between the two 
experimental methods.  At temperatures a few degrees below the 
Teq, denaturation during the course of the experimental run may 
be nearly invisible in the two-minute isothermal batch assay.  The 
three-state EMR model, however, is forced to include the 
cumulative effects of denaturation over a much longer time (the 
time between each data point in the EMR model is 120 seconds, 
the same length as the entire progress curve of the batch model). 
     Thus, at a moderate temperature which is apparently “non-
denaturing” as seen in the shorter batch assay, a significant 
amount of time has passed in the continuous EMR run and there 
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is already much less active enzyme present than if the enzyme 
were being exposed to that temperature for the first time.  Indeed, 
it has been previously shown in the literature that insufficient 
monitoring time, particularly at higher temperatures, can disguise 
the equilibrium character of inactivation and thus make it difficult 
to fit data to a model which would remain consistent in longer 
assays. [17] Effects such as uncooperative unfolding and grace-
period inactivation can influence the accuracy of such short-term 
assays.  
     There is ample evidence in the literature that several strains of 
β-lactamase follow a four-state unfolding mechanism. [18-20]  It 
has been previously established via guanidinium chloride 
denaturation experiments that TEM-1 β-lactamase does not follow 
a simple “one-step, two-state” folding mechanism, but rather 
exhibits a thermodynamically stable intermediate state in 
equilibrium with the native and unfolded states, likely influenced 
by the cis-trans isomerization of Xaa-Pro peptide bonds. [21] This 
intermediate state, described in the literature, is modelled here to 
correspond to the molten globule state of the four-state model. 
     The batch-mode isothermal Equilibrium Model and the non-
isothermal four-state temperature ramp models, remarkably, were 
in good agreement with respect to the location of the Teq, though 
the batch-mode Equilibrium Model predicted a higher ΔHeq.  This 
may be explained because the three-state model is converging 
on an intermediate value somewhere between the enthalpy 
change necessary to enact a conformational change at the active 
site (the ΔHeq of the four-state model), and the enthalpy change 
associated with the onset of unfolding (the ΔHmg of the four-state 
model).  The four-state model makes a distinction between these 
two transitions, in which the molten globule state M exhibits no 
activity but also does not readily become permanently denatured, 
while the unfolded state is much more readily denatured, an 
effect which corresponds to the sudden loss of activity in the 
vicinity of Tmg.  In addition, the nature of the Equilibrium Model 
equation is such that ΔHeq is subject to relatively high errors. [6, 9]  
Discrepancies between the two models may be due to the fact 
that the Equilibrium Model treats the Einact -> X transition as a 
single event, although not necessarily via a single product. [7]  
Alternatively, it may be due to the fact that, for this enzyme, data 
for the Equilibrium Model has only been collected for two minutes. 
The value of Tmg predicted by the temperature-ramp four-state 
trapezoidal model (the better fit of the two four-state models) is 
51.7°C, which coincides almost exactly with the documented Tm 
of the enzyme as measured by circular dichroism. [15] 
     The values for ΔGinact predicted by the four-state continuous 
model were somewhat higher than that of the three-state batch-
mode Equilibrium Model.  Again, this may be attributable to the 
fact that there is a very large time-scale difference between the 
two experiments, and the prediction of the first-order denaturation 
rate constant kinact may appear to be quite different during a two-
minute assay than over the course of several hours. 
     The ΔGcat value of 54.2 kJ/mol predicted by the continuous 
four-state trapezoidal model gives a turnover number of 1530 s-1 
at 25°C, which is in excellent agreement with the literature value 
of 1500 s-1 for TEM-1 using Penicillin G as a substrate. [22] The 
predicted ΔGcat was slightly lower in the three-state batch-mode 
Equilibrium Model, at 53.6 kJ/mol.  This corresponds to a turnover 
number of 2550 s-1 at 25°C.  The discrepancy between these two 
values could be a consequence of experimental error associated 
with the Bradford assay in determining the initial enzyme 
concentration, or it may be due to determinations of kcat having 
been made under conditions for which not all the enzyme is 
active. [7, 23] However, the difference is not far from the sum of 
the fitting and experimental errors expected for the determination 
of Equilibrium Model parameters. [9] 
     The four-state continuous temperature-ramp models predict 
the ΔHmg to be nearly an order of magnitude higher than the ΔHeq 
value, which is in agreement with the notion that the 
conformational shift needed to render the enzyme inactive is 
slight compared to the complete unfolding of the enzyme. [7, 8, 
24, 25] The value of 700 kJ/mol for the enthalpy change upon 
unfolding is in the typical range for globular proteins such as β-
lactamase I from Bacillus cereus, which exhibits a denaturation 
enthalpy of 646 kJ/mol, although this is low compared with 
subtilisin. [ 26] 
     The two numerical integration methods used with the four-
state model (implicit Euler method and trapezoidal rule) predicted 
nearly the same values for ΔGcat, ΔHmg, and ΔGinact.  The two 
methods produced slightly different predictions for the Tmg, which 
may be due to the different behaviour of the two integration 
techniques in the vicinity of Tmg.  The trapezoidal rule method, 
which resulted in a better overall fit, was particularly more 
effective than the implicit Euler method at tracking the 
experimental data in this regime where the rate of change of 
conversion with respect to time is high.  The significant difference 
between the two models was in their predictions of ΔHeq and Teq.  
The implicit Euler method showed a higher Teq with a lower 
energy barrier, while the trapezoidal method showed the 
converse arrangement.  Nevertheless, both methods confirmed 
that ΔHeq was about an order of magnitude less than the ΔHmg 
indicated by both the four-state continuous experiment and CD 
data from literature and that the Teq was at least 10°C lower than 
Tmg (i.e. melting temperature Tm). 
Conclusion 
While the three-state Equilibrium Model (Scheme 1) did not result 
in a good fit to the data obtained via the continuous temperature 
Table 1. Estimation of Deactivation Parameters by Isothermal Batch-mode Tests and Continuous  temperature-ramp EMR Methods 
Method ∆Gcat (kJ/mol) 
ΔHeq 
(kJ/mol) Teq (K) 
ΔHmg 
(kJ/mol) Tmg (K) ΔGinact (kJ/mol) ∑ (residual)2 
Batch Isothermal 53.6 98.5 313.8 - - 92.1 - 
EMR (four-state, Euler) 54.0 64.6 317.9 716.5 328.6 101.2 0.1835 
EMR (four-state, trap.) 54.2 74.9 309.2 699.7 324.7 100.6 0.0497 
EMR (three-state, trap.) 54.8 69.4 330.5 - - 101.0 1.7198 
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ramp method, it resulted in a relatively good fit to the 
isothermally-obtained batch data, though the predicted value of 
ΔGcat was slightly low and the abbreviated increase of actual 
reaction rate with temperature was not fully captured by the 
model.  The four-state deactivation model (Scheme 2), especially 
when the steep changes around Tmg were tracked by a routine 
employing the trapezoidal rule rather than Euler’s method, 
resulted in an excellent fit to the data collected via the continuous 
temperature ramp EMR experiment, and furthermore showed 
good agreement with the batch-mode equilibrium model 
regarding the location of Teq, the temperature of transition 
between native, active enzyme and conformationally-
compromised, inactive enzyme. 
     While the four-state model contains a higher number of fitting 
parameters and should admittedly result in an improved fit over 
the three-state model, there is, as discussed earlier, copious 
evidence in the literature which indicates TEM-1 unfolds via a 
four-state mechanism.  Both the three-state equilibrium and four-
state continuous models were effective at pinpointing the 
transition between active and inactive enzyme.  The finding of two 
distinct transitions in the temperature-ramp EMR model 
corroborates the previously established notion that Teq is separate 
from Topt, with the latter depending on a mix of Teq, ΔGcat, and 
ΔHeq. [5-7] Both are important to engineers who wish to 
characterize and design biocatalysts. It is clear that the difference 
in timescale of these two experimental modes may affect the 
parameters predicted by model fitting.  Denaturing effects which 
may be ignored during an assay lasting only a few minutes will 
have a greater effect on models which seek to capture the 
cumulative deactivation over several hours.  A high degree of 
uncooperativity in the process of transitioning between native and 
denatured states is likely one source of discrepancy between the 
two experimental methods. 
     The discontinuous Equilibrium Model batch method has a 
string of advantages.  The collection of an array of isothermal 
progress curves, while labour-intensive compared to the 
continuous temperature-ramp experiment, can be fitted to a 
model which is mathematically straightforward in that all 
temperature-dependent equilibrium constants remain unchanged 
during progress curves.  The batch method also uses smaller 
quantities of substrates, buffers, and other reagents and can be 
performed with commonplace instrumentation and equipment (i.e. 
no need to configure a CSTR).  In the current study with TEM-1 β-
lactamase, the equilibrium model was equally as capable as the 
more complex four-state continuous model in identifying the Teq of 
the enzyme.  So far, all enzymes for which Equilibrium Model 
data has been collected obey the model. [7, 8] 
     The temperature-ramp method, while it is faster and requires 
minimal direct monitoring, and furthermore utilizes a single 
injection of enzyme (minimizing systematic error), requires a 
model which relies on numerical integration techniques due to the 
complicated behaviour of native enzyme population when 
temperature increases with time.  However, the ability of the 
continuous EMR system, in conjunction with the four-state 
deactivation model, appears to be a powerful tool for examining 
multiple thermodynamic transitions (N to M as well as M to U), 
both of which are of great importance in biocatalyst design, in a 
single experiment.  This technique can likely be extended to other 
biocatalysts which do not deactivate according to a simple two-
state cooperative mechanism. 
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